An 18-month-old, previously well boy presents to his primary care pediatrician with a 2-day history of fever, fussiness, and what his mother interprets as a sore throat because he is crying, eating ...

Bullous pemphigoid, an immune-mediated condition characterized by large, fluid-filled blisters on the skin, is a rare but serious complication of cancer therapy with immune checkpoint inhibitors (ICIs ...

More patients treated with dupilumab experienced sustained disease remission and itch reduction at week 36 compared with those who received placebo. The Food and Drug Administration (FDA) has approved ...

A Prescription Drug User Fee Act target date of June 20, 2025 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics ...

An autoimmune blistering disease of the mucous membranes and skin, pemphigus vulgaris (PV) derives its name from the Greek word, pemphix, for blister. 1 PV is characteristically seen in older patients ...

Please provide your email address to receive an email when new articles are posted on . If approved, Dupixent would be the first and only targeted medicine to treat bullous pemphigoid in the U.S. The ...

Please provide your email address to receive an email when new articles are posted on . Nomacopan was well tolerated and beneficial in patients with bullous pemphigoid, according to phase 2a clinical ...

The two classic forms of impetigo are bullous and nonbullous. Bullous impetigo is sometimes considered a localized form of SSSS. Although found in groups of all ages, impetigo is most commonly seen in ...

Autoimmune bullous disorders constitute a group of rare but potentially life‐threatening dermatological conditions marked by the production of pathogenic autoantibodies directed against structural ...

DEAR DR. ROACH: I am a 73-year-old woman who is in otherwise good health, but I was diagnosed with bullous pemphigoid, a rare autoimmune disease, in January 2022. I have been treated by three ...